Xizang Weixinkang Pharmaceutical Co., Ltd. Class ASSE: 603676

"XIZANG WEIXINKANG PHARMACEUTICAL CO., LTD."Announcement on Receipt of the Approval Notice for Supplementary Application for Potassium Aspartate Injection by a Subsidiary

· Issued by Xizang Weixinkang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Receipt of the Approval Notice for Supplementary Application for Potassium Aspartate Injection by a Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Xizang Weixinkang Pharmaceutical Co., Ltd. Class A

All Xizang Weixinkang Pharmaceutical Co., Ltd. Class A news releases